Rafoxanide Induces Immunogenic Death of Colorectal Cancer Cells.

Cancers (Basel) 2020 05 21;12(5). Epub 2020 May 21.

Department of Systems Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.

Colorectal cancer (CRC) is a major cause of cancer-related death in the world. Emerging evidence suggests that the clinical success of conventional chemotherapy does not merely rely on cell toxicity, but also results from the restoration of tumor immune surveillance. Anti-tumor immune response can be primed by immunogenic cell death (ICD), a form of apoptosis associated with endoplasmic reticulum stress (ERS) induction and the expression/release of specific damage-associated molecular patterns (DAMPs). Unfortunately, a limited number of ICD inducers have been identified so far. The anti-helmintic drug rafoxanide has recently showed anti-tumor activity in different cancer types, including CRC. As such latter effects relied on ERS activation, we here investigated whether rafoxanide could promote ICD of CRC cells. The potential of rafoxanide to induce ICD-related DAMPs in both human and mouse CRC cells was assessed by flow-cytometry, chemiluminescent assay and ELISA. In addition, the immunogenic potential of rafoxanide was assessed in vivo using a vaccination assay. Rafoxanide induced all the main DAMPs (ecto-calreticulin exposure, adenosine triphosphate (ATP)/high mobility group box 1 (HMGB1) release) required for ICD. We observed a marked increase of tumor-free survival among immunocompetent mice immunized with rafoxanide-treated dying tumor cells as compared with sham. Altogether, our data indicate rafoxanide as a bona fide ICD inducer.

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers12051314DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281008PMC
May 2020

Publication Analysis

Top Keywords

potential rafoxanide
8
colorectal cancer
8
crc cells
8
rafoxanide
7
icd
5
cancer types
4
types including
4
marked increase
4
activity cancer
4
drug rafoxanide
4
rafoxanide anti-tumor
4
anti-tumor activity
4
including crc
4
crc effects
4
activation investigated
4
investigated rafoxanide
4
icd observed
4
ers activation
4
effects relied
4
relied ers
4

Similar Publications